Rodrigo Yelin
Rodrigo Yelin
Arcturus Therapeutics
Verified email at arcturusrx.com - Homepage
Title
Cited by
Cited by
Year
Systematic identification of abundant A-to-I editing sites in the human transcriptome
EY Levanon, E Eisenberg, R Yelin, S Nemzer, M Hallegger, R Shemesh, ...
Nature biotechnology 22 (8), 1001-1005, 2004
7112004
Widespread occurrence of antisense transcription in the human genome
R Yelin, D Dahary, R Sorek, EY Levanon, O Goldstein, A Shoshan, ...
Nature biotechnology 21 (4), 379-386, 2003
6872003
Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
S Schuldiner, S Steiner-Mordoch, R Yelin, SC Wall, G Rudnick
Molecular Pharmacology 44 (6), 1227-1231, 1993
1681993
The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters
R Yelin, S Schuldiner
FEBS letters 377 (2), 201-207, 1995
691995
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
H Karchi, G Ronen, R Yelin, L Rabinovich
US Patent 7,910,800, 2011
362011
Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
R Yelin, A Shoshan, E Gold, S Ayal, H Karchi
US Patent 8,962,915, 2015
292015
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
G Ronen, E Gold, R Yelin, R Meissner, H Karchi, S Ayal
US Patent 7,812,218, 2010
262010
EmrE, a small Escherichia coli multidrug transporter, protects Saccharomyces cerevisiae from toxins by sequestration in the vacuole
R Yelin, D Rotem, S Schuldiner
Journal of bacteriology 181 (3), 949-956, 1999
261999
Vesicular monoamine transporters heterologously expressed in the yeast Saccharomyces cerevisiae display high-affinity tetrabenazine binding
R Yelin, S Schuldiner
Biochimica et Biophysica Acta (BBA)-Biomembranes 1510 (1-2), 426-441, 2001
252001
Vesicular neurotransmitter transporters
R Yelin, S Schuldiner
Neurotransmitter Transporters, 313-354, 2002
222002
Glycosylation of a vesicular monoamine transporter: a mutation in a conserved proline residue affects the activity, glycosylation, and localization of the transporter
R Yelin, S Steiner‐Mordoch, B Aroeti, S Schuldiner
Journal of neurochemistry 71 (6), 2518-2527, 1998
211998
Cloning and characterization of a novel human gene RNF38 encoding a conserved putative protein with a RING finger domain
I Eisenberg, H Hochner, T Levi, R Yelin, T Kahan, S Mitrani-Rosenbaum
Biochemical and biophysical research communications 294 (5), 1169-1176, 2002
152002
Molecular and biochemical studies of rat vesicular monoamine transporter
S Schuldiner, S Steiner-Mordoch, R Yelin
Advances in pharmacology 42, 223-227, 1997
121997
Sequences of trail variants
R Yelin, R Khosravi, K Savitzky
US Patent App. 09/855,544, 2002
82002
Multiple-metered self-cleaning dispenser
O Cabiri, R Yelin, E Zlatkis, E Eilat
US Patent 8,783,518, 2014
72014
From Bacterial Antibiotic Resistance to Neurotransmitter Uptake: A Common Theme of Cell Survivala
S Schuldiner, A Shirvan, Y STERN‐BACH, S STEINER‐MORDOCH, ...
Annals of the New York Academy of Sciences 733 (1), 174-184, 1994
71994
Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa
T Marom, R Yelin, A Goldfarb, Y Rakover, L Shlizerman, E Eilat, Y Roth
Otolaryngology—Head and Neck Surgery 143 (4), 492-499, 2010
62010
[4] Purification of vesicular monoamine transporters: From classical techniques to histidine tags
R Yelin, S Schuldiner
Methods in enzymology 296, 64-72, 1998
31998
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
H Karchi, G Ronen, R Yelin, L Rabinovich
US Patent 10,214,749, 2019
22019
From multidrug resistance to vesicular neurotransmitter transport
S Schuldiner, M Lebendiker, S Mordoch, R Yelin, H Yerushalmi
Handbook of Biological Physics 2, 405-431, 1996
21996
The system can't perform the operation now. Try again later.
Articles 1–20